Abstract
Maternal drug use during pregnancy may result in neonatal withdrawal. This statement presents current information about the clinical presentation, differential diagnosis, therapeutic options, and outcome for the offspring associated with intrauterine drug exposure.
Publication types
-
Guideline
-
Practice Guideline
MeSH terms
-
Diagnosis, Differential
-
Humans
-
Infant, Newborn
-
Naloxone / therapeutic use
-
Narcotic Antagonists / therapeutic use
-
Narcotics / adverse effects
-
Narcotics / therapeutic use
-
Neonatal Abstinence Syndrome / diagnosis
-
Neonatal Abstinence Syndrome / drug therapy
-
Neonatal Abstinence Syndrome / therapy*
-
Prognosis
Substances
-
Narcotic Antagonists
-
Narcotics
-
Naloxone